id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-E-0175-0010,FDA,FDA-2009-E-0175,Determination of Regulatory Review Period for Purposes of Patent Extension; VIMPAT-NDA 22-254,Notice,N-Notice,2010-04-23T04:00:00Z,2010,4,2010-04-23T04:00:00Z,2010-06-23T03:59:59Z,2010-04-23T14:26:10Z,2010-09509,0,0,0900006480addf1f
FDA-2009-E-0175-0009,FDA,FDA-2009-E-0175,FDA/CDER to the U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2010-03-31T04:00:00Z,2010,3,2010-03-31T04:00:00Z,,2013-08-11T01:33:31Z,,0,0,0900006480acd626